Enoda Bio is a startup based in the United States.
Enoda Bio develops synthetic cytokine receptor technologies to engineer enhanced cell therapies by unlocking novel cellular signaling pathways for improved therapeutic efficacy and reduced toxicity.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.